Expertise in

conditions

Sibylle F. Loibl

Martin Behaim Str 12,

Neu Isenburg, HE, DE

Expertise in

conditions

Martin Behaim Str 12,

Neu Isenburg, HE, DE

Overview

Sibylle Loibl practices practicing medicine in Neu Isenburg, Germany.

Ms. Loibl is highly rated in 17 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, PIK3CA-Related Overgrowth Spectrum, Triple-Negative Breast Cancer, Breast Cancer in Men, and Mastectomy.

She is actively involved in clinical research, co-authoring 501 peer reviewed articles and participating in 5 clinical trials.

Gender

Female

Locations

Martin Behaim Str 12, Neu Isenburg, HE 63263, Germany

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Prospective and Retrospective Register Study of the German Breast Group (GBG) for Diagnosis and Treatment of Breast Cancer in Pregnancy

Enrollment Status: Unknown

Publish Date: April 17, 2024

An International, Multi-Center, Open-Label, Randomized, Phase III Trial of Sacituzumab Govitecan Versus Treatment of Physician Choice in Patients With Metastatic Triple-Negative Breast Cancer Who Received at Least Two Prior Treatments

Enrollment Status: Completed

Publish Date: June 15, 2022

Intervention Type: Drug

Study Phase: Phase 3

A Multicenter, Randomized, Double-blind, Phase II Study to Evaluate the Tolerability of an Induction Dose Escalation of Everolimus in Patients With Metastatic Breast Cancer

Enrollment Status: Completed

Publish Date: February 23, 2022

Intervention Type: Drug

Study Drugs: Everolimus, Standard Care

Study Phase: Phase 2

A Randomized Phase II Study to Investigate the Addition of PD-L1 Antibody MEDI4736 to a Taxane-anthracycline Containing Chemotherapy in Triple Negative Breast Cancer (GeparNuevo)

Enrollment Status: Completed

Publish Date: February 15, 2021

Intervention Type: Drug

Study Phase: Phase 2

A Prospective, Randomised, Multi-centre Phase II Study Evaluating the Adjuvant, Neoadjuvant or Palliative Treatmant With Tamoxifen +/- GnRH Analogue Versus Aromatase Inhibitor + GnRH Analogue in Male Breast Cancer Patients

Enrollment Status: Completed

Publish Date: September 19, 2018

Intervention Type: Drug

Study Phase: Phase 3

View 4 Less Clinical Trials

501 Total Publications

AGO Breast Panel Recommendations for the use of treatment-relevant biomarkers in early and advanced breast cancer-2026 Update.

Journal: Breast (Edinburgh, Scotland)

Published: April 29, 2026

View All 501 Publications

Frequently Asked Questions about Sibylle F. Loibl

Is Sibylle F. Loibl a top-rated expert for Breast Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Sibylle F. Loibl is classified as an Elite expert for Breast Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Sibylle F. Loibl participate in research or clinical trials?

Yes. Sibylle F. Loibl has published 501 articles and abstracts on conditions like Breast Cancer. You can view a list of Sibylle F. Loibl's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ms. Loibl's expertise for a condition

ConditionClose